FluperlapineAlternative Names: NB 106689
Latest Information Update: 05 Feb 1997
At a glance
- Originator Novartis
- Class Antipsychotics; Dibenzazepines; Small molecules
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 05 Feb 1997 Discontinued-III for Schizophrenia in Switzerland (PO)